Jennifer Lamri

Jennifer Lamri is a seasoned professional in regulatory affairs with extensive experience in managing biological products and CMC (Chemistry, Manufacturing, and Controls) functions. Currently serving as Regulatory Affairs CMC Manager at Recordati Rare Diseases Inc. since April 2022, Jennifer has previously held roles at Sanofi Genzyme, LYSARC, Juvisé Pharmaceuticals, INNOTHERA, and Pierre Fabre, focusing on regulatory strategy development, submission of variations and renewals, and compliance with health authority requirements across various global markets. Educational qualifications include a Master’s degree in Production and Regulatory Affairs for Health Products from Université de Tours and a Bachelor's degree in Biochemistry and Molecular Biology from Université de Bourgogne.